Taher, A. T. Et Al. 2016. Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study. BLOOD CELLS MOLECULES AND DISEASES , vol.57 , 23-29.

Taher, A. T., Cappellini, M. D., AYDINOK, Y., Porter, J. B., Karakas, Z., Viprakasit, V., ... Siritanaratkul, N.(2016). Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study. BLOOD CELLS MOLECULES AND DISEASES , vol.57, 23-29.

Taher, Ali Et Al. "Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study," BLOOD CELLS MOLECULES AND DISEASES , vol.57, 23-29, 2016

Taher, Ali T. Et Al. "Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study." BLOOD CELLS MOLECULES AND DISEASES , vol.57, pp.23-29, 2016

Taher, A. T. Et Al. (2016) . "Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study." BLOOD CELLS MOLECULES AND DISEASES , vol.57, pp.23-29.

@article{article, author={Ali T. Taher Et Al. }, title={Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study}, journal={BLOOD CELLS MOLECULES AND DISEASES}, year=2016, pages={23-29} }